Business Context and Reporting Period
Creative Medical Technology Holdings, Inc. filed this Form 8-K on October 11, 2019, to report the completion of a private placement transaction. The company is incorporated in Nevada and maintains its principal executive offices in Phoenix, Arizona.
Key Financial Metrics
- Capital Raised: $275,000 aggregate purchase price.
- Debt Issued: $297,000 aggregate principal amount of 8% Original Issue Discount Senior Convertible Notes.
- Interest Rate: 8% per annum.
- Maturity Date: October 11, 2020.
- Conversion Terms: Convertible into common stock at 60% of the lowest traded price during the 15 trading days preceding the conversion date.
Material Changes
The filing discloses the entry into a Material Definitive Agreement and the creation of a direct financial obligation. The company sold notes to three institutional investors under Section 4(a)(2) of the Securities Act and Rule 506(b). This transaction represents a new debt obligation and potential future equity dilution not present in prior periods.
Outlook, Risks, and Management Commentary
- Reverse Stock Split Requirement: The Purchase Agreement mandates the company to file a preliminary information statement within 30 days to effect a reverse stock split at a ratio between 1-for-25 and 1-for-75. This split must become effective no later than December 30, 2019.
- Risks: The conversion price mechanism (60% of the lowest traded price) creates significant potential for dilution to existing shareholders. The company is also subject to customary covenants and events of default.
- Financial Statements: This 8-K does not provide updated revenue, profit, cash flow, or liquidity metrics beyond the specific terms of the note issuance.
Investor Verification Checklist
- Verify the execution of the required reverse stock split by the December 30, 2019 deadline.
- Review the attached Securities Purchase Agreement (Exhibit 10.1) for specific covenants and default triggers.
- Monitor the company's stock price volatility, as the conversion price is tied to the lowest traded price over a 15-day period.
- Confirm the identity of the three institutional investors and any related party transactions.